ScholarIQanswers from OpenAlex

Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents

PaperCitations, authors & open-access status

Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents have?

ScholarIQcitation count

Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents published?

ScholarIQyear

Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents has 2024 year in the ScholarIQ index.

What is the open-access status of Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents?

ScholarIQoa status

Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents has closed oa status in the ScholarIQ index.

What is the DOI of Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents?

ScholarIQdoi

The DOI for Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents is on the source record.

What is the OpenAlex record for Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents?

ScholarIQopenalex

The OpenAlex for Solid lipid nanoparticles for pulmonary arterial hypertension: Enhancing solubility and bioavailability of lipophilic phytoconstituents is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial